Ligand Asks Chancery To Toss Costly Formula Error Suit
Ligand Pharmaceuticals Inc. urged Delaware's Chancery Court late Monday to throw out an "opportunistic" investor suit it said aimed to exploit a "scrivener's error" that set up a bogus, multibillion-dollar stock...To view the full article, register now.
Already a subscriber? Click here to view full article